Waters | WAT - Equity Capital And Reserves


Waters reported $15.2B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Agilent USD 7.36B 241M Jun/2026
Align Technology USD 4.23B 83.03M Jun/2026
Bio Techne USD 2.17B 57.47M Sep/2026
Bio-Rad Laboratories USD 7.6B 429.1M Sep/2026
Bruker USD 2.44B 67M Jun/2026
Charles River Laboratories USD 3.23B 387.38M Sep/2026
Danaher USD 53.62B 1.04B Sep/2026
Dentsply International USD 1.36B 4M Sep/2026
General Electric Aerospace USD 17.52B 118M Sep/2026
Illumina USD 3.14B 307M Sep/2026
Intuitive Surgical USD 15.99B 2.18B Sep/2026
IQVIA Holdings USD 6.66B 489M Sep/2026
Laboratory Of America USD 8.85B 241M Sep/2026
Merck USD 44.89B 2.96B Sep/2026
Mettler Toledo International USD 77.66M 64.84M Sep/2026
Myriad Genetics USD 303.9M 33.5M Jun/2026
OraSure Technologies USD 317.78M 4.45M Jun/2026
Quest Diagnostics USD 7.63B 116M Sep/2026
Repligen USD 2.09B 20.29M Sep/2026
Revvity USD 7.23B 46.02M Jun/2026
Thermo Fisher Scientific USD 54.76B 2.08B Sep/2026
Veracyte USD 1.43B 44.86M Sep/2026
Waters USD 15.2B 97M Jun/2026